Abstract
Purpose
To analyze the effects of various obstetric and perinatal factors on the severity of retinopathy of prematurity (ROP).
Methods
Infants born at ≤ 32 weeks of gestation, with less than 1500 g gestational weight and having at least stage 1 ROP, were reviewed. Group1A included treatment-requiring ROP (TR-ROP), and group 2A included the remaining patients not requiring treatment. Group 1B included stage 3 ROP cases, and group 2B included the remaining stage 2 or 1 ROP cases. Group 1C included cases with zone III disease, and group 2C the remaining. The control group (group C) was composed of premature infants without ROP. The multiple comparisons were made among groups 1A, 2A, and C; 1B, 2B, and C; 1C, 2C, and C.
Results
A total of 311 infants were included. Group 1A included 34 cases, group 1B 60, group 1C 51, and group C 98. Antenatal steroid administration, gestational diabetes mellitus (GDM), gestational weight (GW), gestational age (GA), sepsis, continuous positive airway pressure (CPAP) time, and invasive mechanical ventilation (MV) time were associated with TR-ROP, stage 3 ROP, and zone I, and II disease (p < 0.05). Pregestational diabetes mellitus (DM) was only associated with stage 3 ROP (p = 0.031). Gestational hypertension was only associated with zone I and II disease (p = 0.034). The use of low-molecular-weight heparin may be protective against stage 3 disease (p = 0.031).
Conclusion
Antenatal steroid administration, GDM, GW, GA, sepsis, CPAP time, and invasive MV time were risk factors for TR-ROP and stage 3 ROP, while pregestational DM was only associated with stage 3 ROP.
Similar content being viewed by others
Availability of data and material
All the authors have full control of all primary data and agree to allow the International Ophthalmology to review their data upon request.
References
Kim SJ, Port AD, Swan R, Campbell JP, Chan RVP, Chiang MF (2018) Retinopathy of prematurity: a review of risk factors and their clinical significance. Surv Ophthalmol 63:618–637. https://doi.org/10.1016/j.survophthal.2018.04.002
Galantuomo MS, Fossarello M, Cuccu A et al (2016) Rebound macular edema following oral acetazolamide therapy for juvenile X-linked retinoschisis in an Italian family. Clin Ophthalmol 10:2377–2382. https://doi.org/10.2147/OPTH.S114568
Cernichiaro-Espinosa LA, Olguin-Manriquez FJ, Henaine-Berra A, Garcia-Aguirre G, Quiroz-MercadoH M-C (2016) New insights in diagnosis and treatment for Retinopathy of Prematurity. Int Ophthalmol 36:751–760. https://doi.org/10.1007/s10792-016-0177-8
Anwar S, Nath M, Patel A, Lee H, Brown S, Gottlob I, Proudlock FA (2020) Potential utility of foveal morphology in preterm infants measured using hand-held optical coherence tomography in retinopathy of prematurity screening. Retina (Philadelphia, Pa.) 40:1592–1602. https://doi.org/10.1097/IAE.0000000000002622
Au SC, Tang SM, Rong SS, Chen LJ, Yam JC (2015) Association between hyperglycemia and retinopathy of prematurity: a systemic review and meta-analysis. Sci Rep 5:9091. https://doi.org/10.1038/srep09091
Chan PY, Tang SM, Au SC et al (2016) Association of gestational hypertensive disorders with retinopathy of prematurity: a systematic review and meta-analysis. Sci Rep 6:30732. https://doi.org/10.1038/srep30732
Smith LM, Qureshi N, Chao CR (2000) Effects of single and multiple courses of antenatal glucocorticoids in preterm newborns less than 30 weeks’ gestation. J Matern Fetal Med 9:131–135
Yim CL, Tam M, Chan HL et al (2018) Association of antenatal steroid and risk of retinopathy of prematurity: a systematic review and meta-analysis. Br J Ophthalmol 102:1336–1341. https://doi.org/10.1136/bjophthalmol-2017-311576
Arima M, Tsukamoto S, Fujiwara K, Murayama M, Fujikawa K, Sonoda KH (2017) Late onset circulatory collapse and continuous positive airway pressure are useful predictors of treatment-requiring retinopathy of prematurity: a 9-year retrospective analysis. Sci Rep 7:3904. https://doi.org/10.1038/s41598-017-04269-5
Wang X, Tang K, Chen L, Cheng S, Xu H (2019) Association between sepsis and retinopathy of prematurity: a systematic review and meta-analysis. BMJ Open 9:e025440. https://doi.org/10.1136/bmjopen-2018-025440
AlRyalat SA, Al Oweidat K, Al-Amer A et al (2020) Perinatal events predicting retinopathy of prematurity in extremely pre-term infants. J Neonatal Perinatal Med 13:261–266. https://doi.org/10.3233/NPM-190336
Kindinger LM, David AL (2019) The role of the obstetrician in the prevention of retinopathy of prematurity. Semin Perinatol 43:323–332. https://doi.org/10.1053/j.semperi.2019.05.003
Gilbert CE, Dawes L, Wise M, Darlow BA (2019) Obstetric strategies to reduce blindness from retinopathy of prematurity in infants born preterm. Acta Obstet Gynecol Scand 98:1497–1499. https://doi.org/10.1111/aogs.13684
International Committee for the Classification of Retinopathy of Prematurity (2005) The international classification of retinopathy of prematurity revisited. Arch Ophthalmol 123:991–999. https://doi.org/10.1001/archopht.123.7.991
Chaves-Samaniego MJ, García Castejón M, Chaves-Samaniego MC et al (2020) Risk calculator for retinopathy of prematurity requiring treatment. Front Pediatr 8:529639. https://doi.org/10.3389/fped.2020.529639
Huang J, Tang Y, Zhu T, Li Y et al (2019) Cumulative evidence for association of sepsis and retinopathy of prematurity. Medicine (Baltimore) 98:e17512. https://doi.org/10.1097/MD.0000000000017512
Kemp MW, Newnham JP, Challis JG, Jobe AH, Stock SJ (2016) The clinical use of corticosteroids in pregnancy. Hum Reprod Update 22:240–259. https://doi.org/10.1093/humupd/dmv047
Karna P, Muttineni J, Angell L, Karmaus W (2005) Retinopathy of prematurity and risk factors: a prospective cohort study. BMC Pediatr 5:18. https://doi.org/10.1186/1471-2431-5-18
Lee JH, Zhang J, Massmann GA, Figueroa JP (2014) Antenatal betamethasone increases vascular reactivity to endothelin-1 by upregulation of CD38/cADPR signaling. J Dev Orig Health Dis 5:56–62. https://doi.org/10.1017/S2040174413000512
Hodyl NA, Crawford TM, McKerracher L, Lawrence A, Pitcher JB, Stark MJ (2016) Antenatal steroid exposure in the late preterm period is associated with reduced cord blood neurotrophin-3. Early Hum Dev 101:57–62. https://doi.org/10.1016/j.earlhumdev.2016.03.016
Tremblay S, Miloudi K, Chaychi S et al (2013) Systemic inflammation perturbs developmental retinal angiogenesis and neuroretinal function. Invest Ophthalmol Vis Sci 54:8125–8139. https://doi.org/10.1167/iovs.13-12496
Lende M, Rijhsinghani A (2020) Gestational diabetes: overview with emphasis on medical management. Int J Environ Res Public Health 17:9573. https://doi.org/10.3390/ijerph17249573
Bernardes TP, Zwertbroek EF, Broekhuijsen K et al (2019) Delivery or expectant management for prevention of adverse maternal and neonatal outcomes in hypertensive disorders of pregnancy: an individual participant data meta-analysis. Ultrasound Obstet Gynecol 53:443–453. https://doi.org/10.1002/uog.20224
Mishra S, Rao CR, Ab S (2016) Trends in the diagnosis of gestational diabetes mellitus. Scientifica (Cairo) 2016:5489015. https://doi.org/10.1155/2016/5489015
Naderi S, Tsai SA, Khandelwal A (2017) Hypertensive disorders of pregnancy. Curr Atheroscler Rep 19:15. https://doi.org/10.1007/s11883-017-0648-z
Mohamed S, Murray JC, Dagle JM, Colaizy T (2013) Hyperglycemia as a risk factor for the development of retinopathy of prematurity. BMC Pediatr 13:78. https://doi.org/10.1186/1471-2431-13-78
Razak A, Faden M (2021) Association of maternal diabetes mellitus with preterm infant outcomes: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed 106:271–277. https://doi.org/10.1136/archdischild-2020-320054
Kaempf JW, Kaempf AJ, Wu Y, Stawarz M, Niemeyer J, Grunkemeier G (2011) Hyperglycemia, insulin and slower growth velocity may increase the risk of retinopathy of prematurity. J Perinatol 31:251–257. https://doi.org/10.1038/jp.2010.152
Opara CN, Akintorin M, Byrd A, Cirignani N, Akintorin S, Soyemi K (2020) Maternal diabetes mellitus as an independent risk factor for clinically significant retinopathy of prematurity severity in neonates less than 1500g. PLoS ONE 15:e0236639. https://doi.org/10.1371/journal.pone.0236639
Tunay ZÖ, Özdemir Ö, Acar DE, Öztuna D, Uraş N (2016) Maternal diabetes as an independent risk factor for retinopathy of prematurity in infants with birth weight of 1500 g or more. Am J Ophthalmol 168:201–206. https://doi.org/10.1016/j.ajo.2016.05
Garg R, Agthe AG, Donohue PK, Lehmann CU (2003) Hyperglycemia and retinopathy of prematurity in very low birth weight infants. J Perinatol 23:186–194. https://doi.org/10.1038/sj.jp.7210879
Ge G, Zhang Y, Zhang M (2021) Pregnancy-induced hypertension and retinopathy of prematurity: a meta-analysis. Acta Ophthalmol. https://doi.org/10.1111/aos.14827.Advanceonlinepublication.10.1111/aos.14827
Zayed MA, Uppal A, Hartnett ME (2010) New-onset maternal gestational hypertension and risk of retinopathy of prematurity. Invest Ophthalmol Vis Sci 51:4983–4988. https://doi.org/10.1167/iovs.10-5283
Leaf RK, Connors JM (2017) The role of anticoagulants in the prevention of pregnancy complications. Clin Appl Thromb Hemost 23:116–123. https://doi.org/10.1177/1076029615615972
Aydin H, Gunay M, Celik G, Gunay BO, Aydin UT, Karaman A (2016) Evaluation of Factor V Leiden, Prothrombin G20210A, MTHFR C677T and MTHFR A1298C gene polymorphisms in retinopathy of prematurity in a Turkish cohort. Ophthalmic Genet 37:415–418. https://doi.org/10.3109/13816810.2015.1126611
Visser L, de Boer MA, de Groot CJM et al (2017) Low dose aspirin in the prevention of recurrent spontaneous preterm labour–the APRIL study: a multicenter randomized placebo controlled trial. BMC Pregnancy Childbirth 17:223. https://doi.org/10.1186/s12884-017-1338-0
Gursoy H, Bilgec MD, Erol N, Basmak H, Colak E (2016) The macular findings on spectral-domain optical coherence tomography in premature infants with or without retinopathy of prematurity. Int Ophthalmol 36:591–600. https://doi.org/10.1007/s10792-016-0176-9
Chang JW (2019) Risk factor analysis for the development and progression of retinopathy of prematurity. PLoS ONE 14:e0219934. https://doi.org/10.1371/journal.pone.0219934
Acknowledgements
The paper is edited for proper language by AJE editors. Certificate Verification Key is 3695-38C9-3424-574F-61DE.
Author information
Authors and Affiliations
Contributions
All of the authors meet all four of the following conditions: 1. Make substantial contributions to conception and design, and/or acquisition of data, and/or analysis and interpretation of data; 2. Participate in drafting the article or revising it critically for important intellectual content; 3. Give final approval of the version to be submitted; 4. Agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Corresponding author
Ethics declarations
Conflict of interest
The authors do not have any financial conflicts of interest related to the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ozgur Gursoy, O., Gurer, H.G., Yildiz Eren, C. et al. The association of various obstetric and perinatal factors with retinopathy of prematurity. Int Ophthalmol 42, 2719–2728 (2022). https://doi.org/10.1007/s10792-022-02260-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10792-022-02260-2